DoW Vision, Translational Research Award

Funding Opportunity Number: HT942526VRPTRA

Posted Date: May 05, 2026 | Closing Date: Nov 12, 2026

Estimated Total Program Funding: $1,600,000

About the Opportunity

The fiscal year 2026 (FY26) Vision Research Program (VRP) Translational Research Award (TRA) supports translational research that transforms a promising discovery into new drugs, devices, or clinical practice guidelines ready for definitive testing in clinical trials during or by the end of the period of performance. The TRA may fund preclinical studies, clinical research, or a pilot clinical trial but not a full-scale clinical trial. Research must align with at least one of the FY26 VRP Focus Areas.

Eligibility

Open to any type of entity, unrestricted. If developing new drugs or devices, the research team must include expertise in the regulatory approval process.

Distinctive Features

• Includes a Partnering Principal Investigator (PI) Option (PPIO) for two PIs: an Initiating PI and a Partnering PI.
• Scored peer review criteria:
  • Research Idea/Rationale
  • Research Strategy and Feasibility
  • Impact
  • Personnel
  • Post-Award Transition Plan
• Programmatic review criteria:
  • Adherence to the intent of the TRA
  • Contribution to the VRP portfolio
  • Relative impact and relevance to military health
• The VRP may share FY26 TRA applications and reviews with the National Eye Institute (NEI) for independent funding consideration.

Additional Information

Grant Announcement

For assistance, contact the eBRAP Help Desk at 301-682-5507 or help@eBRAP.org.